Harvard Apparatus Regenerative Technology, Inc. - 10-Q Filing

Harvard Apparatus Regenerative Technology reports Q3 2026 segment results with Regenerative Biotech bearing substantially all G&A expenses.

SEC EDGAR · November 13, 2026, 16:22 UTC

Tickers: $HRGN

More Regulatory news

Royale Energy, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:46 UTC
Blue Chip Capital Group Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 16:34 UTC
MOVING iMAGE TECHNOLOGIES INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:28 UTC
Blue Acquisition Corp/Cayman - 8-K Filing SEC EDGAR · November 13, 2026, 16:11 UTC
Skyline Bankshares, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 15:57 UTC
Quetta Acquisition Corp - 10-Q Filing SEC EDGAR · November 13, 2026, 15:13 UTC
UWHARRIE CAPITAL CORP - 8-K Filing SEC EDGAR · November 13, 2026, 15:02 UTC
MOBIX LABS, INC - 8-K Filing SEC EDGAR · November 13, 2026, 14:50 UTC
FIRST NATIONAL CORP /VA/ - 8-K Filing SEC EDGAR · November 13, 2026, 14:48 UTC
Utz Brands, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 14:49 UTC